Investigation of the structure variation of metal diphosphonates with the changing of N-donor auxiliary ligands and their properties [PDF]
, 2014 Nine metal diphosphonates, [Co(H2L)(pyz)(H2O)][(H2O)0.3] (1), [Ni(H2L)(pyz)(H2O)2] (2), [Ni(H2L)(2,2′-bipy)2][(H2O)2] (3), [Ni(H2L)(4,4′-bipy)(H2O)][(H2O)2] (4), [Ni(H2L)(dpe)(H2O)2][(H2O)2] (5), [Cu(H2L)(pyz)(H2O)2] (6), [Cu(H2L)(4,4′-bipy)][(H2O)2] (7),
Si‐Fu Tang +3 more
openalex +2 more sources
New azaheterocyclic aromatic diphosphonates for hybrid materials for fuel cell applications [PDF]
, 2013 New azaheterocyclic aromatic diphosphonate derivatives of benzimidazole and benzotriazole were synthesized by nickel-catalyzed Arbuzov reaction of 4,7-dibromo-2,1,3-benzothiadiazole with triethyl phosphite, followed by reductive sulfur extrusion reaction
Fátima C. Teixeira +2 more
openalex +2 more sources
Molecular theranostics: principles, challenges and controversies. [PDF]
J Med Radiat SciMolecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Currie G.
europepmc +2 more sources
The Rehabilitation of Partially Edentulous Maxilla With Unilateral Zygomatic Implants: A Retrospective Study up to 23 Years Follow-Up. [PDF]
Clin Oral Implants ResABSTRACT Objectives This retrospective study aimed to evaluate the clinical outcomes associated with zygomatic implant (ZI) rehabilitation in partially atrophic edentulous maxillae over a mean follow‐up period of more than 10.3 years. Methods All consecutive patients underwent ZI rehabilitation between 1999 and 2020, with a minimum follow‐up period of ...
Fan S +3 more
europepmc +2 more sources
Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats [PDF]
Journal of Applied Oral Science, 2023 Medication-related osteonecrosis of the jaw (MRONJ) is characterized by bone exposure for more than eight weeks in patients who have used or been treated with antiresorptive or antiangiogenic drugs, without a history of radiation therapy or metastatic ...
Wilson José de Miranda LIMA +7 more
doaj +1 more source
Drugs in Context, 2020 Background: On stopping bisphosphonate treatment, bone resorption may increase before evidence of a decrease in bone density. Offset of bisphosphonate effect may therefore be monitored by measuring C-terminal telopeptide (CTX) following long-term ...
Louise Statham +2 more
doaj +1 more source
Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis [PDF]
Vojnosanitetski Pregled, 2014 nema
Gavrić Miodrag +6 more
doaj +1 more source
Diagnostics, 2021 Complex regional pain syndrome type I (CRPS I)—or algodystrophy—is a rare disease that usually occurs after a traumatic event. It is characterized by typical clinical findings such as severe and disabling pain disproportionate to the injury, functional ...
Antimo Moretti +6 more
doaj +1 more source
The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain [PDF]
, 2022 Neridronate or ((6-amino-1-hydroxy-1-phosphonohexyl) phosphonic acid) is an amino-bisphosphonate (BP) synthetized in Italy in 1986. Bisphosphonates are molecules with a P-C-P bond in their structure that allows strong and selectively binding to ...
Antimo Moretti, Giovanni Iolascon
core +1 more source
Exploring bacterial metalloproteases as promising drug targets [PDF]
, 2022 Microbial infection and the rise of antibiotic resistance pose a serious threat to public health. To tackle bacterial infection and resistance, new bacterial targets and non-antibiotic treatment options need to be identified.
Alhayek, Alaa
core +1 more source